Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
linoleic acid/càncer
L'enllaç es desa al porta-retalls
11 resultats
Pharmaceutical and dietary composition
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series
Pharmaceutical and dietary composition
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series
Pharmaceutical and dietary composition
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 or (.omega.-3) series
Lipids for treatment of disease
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present application generally relates to methods of treating animals, including humans. More particularly, it relates to methods of treating animals by maintaining or increasing the CD-4 and CD-8 lymphocyte cell populations or levels in said animals. It is known that
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present application generally relates to methods of treating animals, including humans. More particularly, it relates to methods of treating animals by maintaining or increasing the CD-4 and CD-8 lymphocyte cell populations or levels in said animals. It is known that
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
RELATED CASE
The present application is a continuation-in-part of pending U.S. patent application Ser. No. 07/875,896 filed Apr. 29, 1992.
FIELD OF THE INVENTION
The present application generally relates to methods of treating animals, including humans. More particularly, it relates to methods of
Safflower with elevated gamma-linolenic acid
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
Gamma-linolenic acid (GLA) is an essential fatty acid in the omega-6 family that is found primarily in plant-based oils. GLA is synthesized from linoleic acid (LA) via the action of the enzyme delta-six desaturase (.DELTA.6-desaturase). The beneficial effects of GLA
Method of stabilizing and potentiating the action of anti-angiogenic substances
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious
Method of stabilizing and potentiating the action of anti-angiogenic substances
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious
Method of stabilizing and potentiating the action of anti-angiogenic substances
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
